CELEBRATING 16 YEARS OF BEING #1 IN COMPLIANCE
Agilent Profile
An independent survey has ranked Agilent #1 for Compliance Services since 1995. Agilent Enterprise Edition is used in regulated laboratories, including standard organizations, regulatory agencies, and a global top-3 pharmaceutical firm.
CLEARLY BETTER AGAIN
Why is Agilent consistently the leader in compliance services? In the words of our customers:
- “The ACE protocol passed all corporate quality levels and national agency audit”
- “One harmonized compliance protocol for all labs speeds up protocol review for operators”
- “Our lab sample backlog was reduced by 75%”
Agilent Enterprise Edition provides fully automated, metrology-based instrument qualification —no matter which CDS you’re using —all while reducing your regulatory risk. We deliver Clearly Better Compliance.
CONSISTENCY THROUGH AUTOMATION
Our automated approach ensures that Agilent Enterprise Edition:
- Consistently performs qualification testing
- Consistently provides validated calculations
- Consistently delivers harmonized reports
When you need virtually audit-proof analytical instrument qualification—for your Agilent systems or those from other manufacturers—don't choose just any compliance provider. Choose the leader. Choose Agilent Enterprise Edition.
Learn more and get a FREE white paper and qualification primer.
Evaluating Antimicrobial Potential of Articaine Derivatives in Oral Infections with CMC
May 20th 2025Cell membrane chromatography (CMC) technology was used by researchers in screening efficacy and antibacterial ability of articaine (AT) derivatives in the pre-emptive treatment of oral infections.
Hydrophilic Interaction Chromatography (HILIC) and Direct Online Disruption of Lipid Nanoparticles
May 19th 2025Two proof-of-concept hydrophilic interaction chromatography HILIC) methods were developed in a joint study conducted by the University of Geneva (Switzerland), Sanofi, and the Waters Corporation—one for disrupting LNPs and retaining the mRNA, and another for detecting only unencapsulated mRNA to assess encapsulation efficiency. LCGC International spoke to Jonathan Maurer, first author of the paper that resulted from this study, about the methods and the efforts that led up to their development.
This article discusses how integrating seven prioritization strategies can enhance compound identification, support environmental risk assessment, and accelerate decision-making.
